FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_HR_1026.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2021-02-11.
What are the main provisions?
Key points include:
- All opioid medications will be required to carry labels warning of dependence, addiction, and overdose risks.
- Transferring prescribed opioid drugs to others will be explicitly defined as a prohibited act.
- New labeling and prohibition rules will become effective within two years of the act's enactment.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Stanton, Greg [D-AZ-9].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.